OpenVSafe by OpenVAERS
Search V-safe

7YR-26086-71357

3 vaccinations 6 coded responses 13 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
648 / MO
Registered
2021-12-30
Relationship
Self
Race
American Indian or Alaska Native
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2344773 (opens in a new window) high 10 / 11 — 4 of 11 VAERS symptoms same dose (3) MO matches 2021-12-29 / 2022-05-30 / 2022-06-30
received the same day as the last call
case 814000

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-28
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-18
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-29
    Dose 3 — Pfizer-BioNTech
  4. 2021-12-30
    Registered in v-safe
  5. 2022-01-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  6. 2022-01-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  7. 2022-01-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  8. 2022-01-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  9. 2022-01-05
    Health check-in — day 7, dose 3
    Feeling: Good · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  10. 2022-01-12
    Survey response — day 14, dose 3
    MedDRA: Abdominal pain, Diarrhoea, Nausea, Pain, Vomiting — Feeling: Good · Be unable to do your normal daily activities
    Free text: Severe abdominal pain & nausea/vomiting/diarrhea along with body aches
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-01-19
    Survey response — day 21, dose 3
    MedDRA: Chest discomfort, Chills, Cough, Fatigue, Headache, Nasal congestion, Oropharyngeal pain, Pain, Rhinorrhoea, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Chills, body aches, fatigue, sore throat, cough, runny nose, stuffy nose, headache, chest tightness · Healthcare visit (other): Waiting on tests results to be able to see doctor
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-01-19
    Report sent to call center — day 21, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  13. 2022-01-20
    Call successful
    Completed over the phone
  14. 2022-01-26
    Survey response — day 28, dose 3
    MedDRA: Dizziness, Fatigue, Headache, Nasal congestion, Nausea, Oropharyngeal pain, Pain, Rhinorrhoea, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Severe nausea/vomiting, extreme fatigue, body aches/pains, sore throat, runny/stuffy nose, headache, dizziness
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-01-26
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  16. 2022-01-27
  17. 2022-02-02
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  18. 2022-02-09
    Survey response — day 42, dose 3
    MedDRA: Abdominal pain, Diarrhoea, Nausea, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Abdominal pain, nausea, vomiting, diarrhea
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-02-09
    Report sent to call center — day 42, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  20. 2022-02-11
  21. 2022-03-30
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  22. 2022-06-29
    Survey response — 6 months, dose 3
    MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: COVID, infection in blood
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-06-29
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  24. 2022-06-30
    Call successful
    Completed over the phone
  25. 2022-06-30
    Call successful
    Completed over the phone
  26. 2022-06-30
    Call successful
    Completed over the phone
  27. 2022-12-29
    Survey response — 12 months, dose 3
    MedDRA: Renal disorder, Vasculitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Vasculitis & kidney disease
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-12-29
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  29. 2022-12-30
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12020-12-28Pfizer-BioNTech No
22021-01-18Pfizer-BioNTech No
32021-12-29Pfizer-BioNTech No

Call center

5 call center cases

5 successful

VAERS report filed, before or during a call: 5

See the call center timeline

Free text

Release 10 — day 14, dose 3

2022-01-12

Symptoms: Severe abdominal pain & nausea/vomiting/diarrhea along with body aches

Release 10 — day 21, dose 3

2022-01-19

Symptoms: Chills, body aches, fatigue, sore throat, cough, runny nose, stuffy nose, headache, chest tightness
Healthcare visit (other): Waiting on tests results to be able to see doctor

Release 11 — day 28, dose 3

2022-01-26

Symptoms: Severe nausea/vomiting, extreme fatigue, body aches/pains, sore throat, runny/stuffy nose, headache, dizziness

Release 11 — day 42, dose 3

2022-02-09

Symptoms: Abdominal pain, nausea, vomiting, diarrhea

Release 12 — 6 months, dose 3

2022-06-29

Symptoms: COVID, infection in blood

Release 12 — 12 months, dose 3

2022-12-29

Symptoms: Vasculitis & kidney disease

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDAbdominal pain · · ✓
SDChest discomfort · · ✓
SDChills · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDiarrhoea · · ✓
SDDizziness · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDNasal congestion · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDRenal disorder · · ✓
SDRhinorrhoea · · ✓
SDVasculitis · · ✓
SDVomiting · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release